
Startup accelerator and early-stage investor running intensive batches for new technology founders

Thesis-driven, research-centred investment firm backing early technology nearing commercialisation

Compound is a New York investment firm that works from research-based theses. It focuses on frontier technology that is close to commercialisation, and helps founders after investing.
Compound works with founders building technology companies. A recent post describes an investment in Anagen, and the firm has welcomed Jason Kelly as a venture partner.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images — click to enlarge
As of 2026-10-05. Organic ranks only; sponsored placements are never ranks.
No questions yet. Be the first to ask about Compound.
Similar listings buyers compare against this one.

Startup accelerator and early-stage investor running intensive batches for new technology founders

BlockTower Capital

Vision Venture Capital

Convergent Investors

Pacific Venture Capital

Tomales Bay Capital
Everything here links back to the same verified catalogue. Pick your next stop.